CDXC Earning Date, Earning Analysis and Earning Prediction

Quarterly Results

CDXC Earnings Forecast

Looking ahead, CDXC remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2024/Q4 project quarter revenue of 26.51M and an EPS of 0.02.

However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2024 have been unchanged by 0%, while EPS estimates have been unchanged by 0%. For the upcoming Q4 2024, revenue estimates have been adjusted unchanged by 0%. These revisions correlate with a 0% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in CDXC long-term fundamentals.

The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

RevenueEPS

Currency: USD

Revenue Estimate-:0

EPS Estimate-:0

—

Stock Price0

Revenue Estimates for FY2024

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2024

No Change

0.00%

In Past 3 Month

Revenue Estimates for Q4 2024

No Change

0.00%

In Past 3 Month

Earnings Forecast

Revenue

EPS

Currency: USD

Actual

Estimate

AI Analysis

Earnings Surprise Analysis

Revenue

EPS

AI Analysis

Earnings Reaction

The chart below shows how CDXC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CDXC sees a -4.92% change in stock price 10 days leading up to the earnings, and a 20.68% change 10 days following the report. On the earnings day itself, the stock moves by 1.98%. This data can give you a slight idea of what to expect for the next quarter's release.

For example, in DEC/2024, the stock changed 52.68% on the day following the earnings release and then changed by 40.54% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of CDXC's latest earnings report for FY2024Q4?

CDXC reported its FY2024Q4 earnings on 2025-03-04, showcasing a revenue of 29.13M against an estimate of 26.51M, resulting in a 9.88% surprise. The EPS was 0.09, surpassing the expected 0.02 by 350%. The stock experienced a 52.68% price change on the earnings day and a 41.07% change over the next five days, reflecting market reactions to the results.

How did CDXC's stock price react after the FY2024Q4 earnings release?

Following CDXC's FY2024Q4 earnings announcement on 2025-03-04, the stock price moved by 52.68% on the day of the release. Over the subsequent five days, it saw a 41.07% change. Historically, CDXC's stock price tends to shift by an average of -4.92% in the 10 days leading up to earnings and 20.68% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for CDXC for 2024/Q4?

For 2024/Q4, analysts estimate CDXC's annual revenue to reach 26.51M, while the EPS is projected at 0.02. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

How does CDXC's stock price correlate with earnings forecast revisions?

The correlation between CDXC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2024 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from CDXC's next earnings report?

Based on historical trends, CDXC's stock price typically moves by -4.92% in the 10 days before its earnings and 20.68% in the 10 days after. For the upcoming 2024/Q4 earnings, analysts expect an EPS of 0.02 and revenue of 26.51M.

What is the sentiment in Chromadex Corp (CDXC) Q4 2024 Earnings Call Summary?

The company reported record revenue growth and strong e-commerce performance, which are positive indicators. Despite some supply chain issues, management remains optimistic about growth, especially with the Niagen IV expansion and potential partnerships. The Q&A revealed uncertainties in the NO PARK study and NAD+ testing, but these were not major concerns. Overall, the positive revenue outlook and strong product development outweigh the minor uncertainties, suggesting a positive stock price movement in the near term.